Real-life data of abiraterone acetate and enzalutamide treatment in post-chemotherapy metastatic castration-resistant prostate cancer in Poland

Overview of attention for article published in Frontiers in oncology, April 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 11 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 26,146 followers.

Real-life data of abiraterone acetate and enzalutamide treatment in post-chemotherapy metastatic castration-resistant prostate cancer in Poland https://t.co/P8na7t2Ir4 https://t.co/KXJeXCMSdg

14 Apr 2023

Reply Repost Favourite

New research: Real-life data of abiraterone acetate and enzalutamide treatment in post-chemotherapy metastatic castration-resistant prostate cancer in Poland: Background Abiraterone acetate (ABI) and Enzalutamide (ENZA) are second-generation… https://t.co

14 Apr 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.